Sarah Akerman
About Sarah Akerman
Sarah Akerman is the Executive Medical Director of Medical Affairs Strategy at Alkermes, with a background in psychiatry and addiction treatment.
Current Role at Alkermes
Sarah Akerman currently serves as the Executive Medical Director, Medical Affairs Strategy at Alkermes in Waltham, MA. In this role, she is responsible for the medical strategy and lifecycle management for a psychiatry franchise. Her expertise provides valuable insights to cross-functional partners within the company, ensuring effective implementation of medical strategies.
Previous Academic and Clinical Positions
Prior to her current role, Sarah Akerman held several significant positions at Dartmouth-related institutions. She was an Assistant Professor of Psychiatry at the Geisel School of Medicine at Dartmouth from 2013 to 2016. Concurrently, she managed the Perinatal Addiction Treatment Program as its Medical Director at Dartmouth-Hitchcock and completed an Addiction Psychiatry Research Fellowship. She also completed an Addiction Psychiatry Clinical Fellowship from 2012 to 2013 and a Psychiatry Residency from 2008 to 2012 at Dartmouth-Hitchcock.
Educational Background
Sarah Akerman earned her Doctor of Medicine (MD) from the University of Miami Leonard M. Miller School of Medicine, where she studied from 2004 to 2008. Before that, she achieved a Bachelor of Arts (B.A.) in Music from Tufts University, where she studied from 1996 to 2000.
Expertise in Psychiatry and Addiction
Sarah Akerman is a board-certified addiction psychiatrist with extensive experience in the research and clinical care of patients with substance use and psychiatric disorders. Her knowledge and skills make her a key figure in building and strengthening relationships with opinion leaders and organizations in the medical field. She serves as an Adjunct Assistant Professor of Psychiatry at the Dartmouth Geisel School of Medicine, further contributing to her academic and clinical expertise.